Combination high-dose omega-3 fatty acids and high-dose cholecalciferol in new onset type 1 diabetes: A potential role in preservation of beta-cell mass

David Baidal, Camillo Ricordi, M. Garcia-Contreras, A. Sonnino, A. Fabbri

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Several studies have evaluated the role of inflammation in type 1 diabetes (T1D). The safety profile and anti-inflammatory properties of high dose omega-3 fatty acids combined with Vitamin D supplementation make this therapy a possible candidate for T1D intervention trials. Herein, we describe the case of a 14-yearold boy with new onset T1D treated with high dose Omega-3 and vitamin D3. By 12 months, peak C-peptide increased to 0.55 nmol/L (1.66 ng/mL) corresponding to a 20% increment from baseline and AUC C-peptide was slightly higher compared to 9 months (0.33 vs. 0.30 nmol/L/min) although remaining slightly lower than baseline. Combination high-dose Omega-3 fatty acids and high-dose vitamin D3 therapy was well tolerated and may have beneficial effects on betacell function. Randomized controlled trials could be of assistance to determine whether this therapy may result in the preservation of betacell function in patients with new onset T1D.

Original languageEnglish (US)
Pages (from-to)3313-3318
Number of pages6
JournalEuropean Review for Medical and Pharmacological Sciences
Volume20
Issue number15
StatePublished - Aug 1 2016

Keywords

  • Autoimmunity
  • Diabetes
  • Fatty acids
  • Inflammation
  • Omega-3
  • Vitamin D

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Combination high-dose omega-3 fatty acids and high-dose cholecalciferol in new onset type 1 diabetes: A potential role in preservation of beta-cell mass'. Together they form a unique fingerprint.

  • Cite this